Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids
Viral infections, such as those caused by Herpes Simplex Virus-1 (HSV-1) and SARS-CoV-2, affect millions of people each year. However, there are few antiviral drugs that can effectively treat these infections. The standard approach in the development of antiviral drugs involves the identification of...
Saved in:
Main Authors: | Gill Diamond (Author), Natalia Molchanova (Author), Claudine Herlan (Author), John A. Fortkort (Author), Jennifer S. Lin (Author), Erika Figgins (Author), Nathen Bopp (Author), Lisa K. Ryan (Author), Donghoon Chung (Author), Robert Scott Adcock (Author), Michael Sherman (Author), Annelise E. Barron (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection
by: Maxim Lebedev, et al.
Published: (2024) -
The study of Antiviral Effects of Glycyrrihza Glabra Extract on HSV
by: SHR Monavari, et al.
Published: (2008) -
Review: Structure-Activity Relationship of Antimicrobial Peptoids
by: Priscilla L. Nyembe, et al.
Published: (2023) -
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
by: Daan W. Huntjens, et al.
Published: (2023) -
Novel Cationic Meso-Arylporphyrins and Their Antiviral Activity against HSV-1
by: Kseniya A. Zhdanova, et al.
Published: (2021)